comparing two different methods of giving drug magnesium sulfate for treating after surgery sore throat
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2020/09/028047
- Lead Sponsor
- rajarajeswari medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Adult patients between 18-65 yr of age of either sex.
2. ASA status I and II
3. Undergoing unilateral PCNL and RIRS surgeries.
Exclusion Criteria
1. Patients refusing to participate in the study
2. Patient with uncontrolled hypertension, diabetes, cardio-respiratory disorders, neuro-psychiatric disorders, hepatic or renal dysfunction.
3. Surgery involving the oral cavity, nasopharynx, larynx and neck regions.
4. History of preoperative sore throat, common cold, anticipated difficult airway.
5. Pregnant or lactating mothers.
6. Recent use of antiinflammatory drugs
7.Allergic to study drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ebulised Magnesium Sulphate is better compared to Intravenous Magnesium SulphateTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Safety profile of Magnesium Sulphate at 10mcg/ kg both Intravenously and NebulisationTimepoint: 3 months